PD-1 BLOCKAGE WITH NIVOLUMA IN UNTREATED HODGKIN'S LYMPHOMA

CY1126298T1Undetermined Publication Date: 2026-07-31BRISTOL MYERS SQUIBB CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CY20231100507T
Authority / Receiving Office
CY · CY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2016-06-02
Filing Date
2023-09-20
Publication Date
2026-07-31
Estimated Expiration
2043-09-20
Patent Text Reader

Abstract

This disclosure provides methods for treating Hodgkin lymphoma in a subject comprising nivolumab, a PD-1 blocking antibody, which inhibits immune-tumor attack in patients with relapsed or refractory Hodgkin lymphoma.
Need to check novelty before this filing date? Find Prior Art